Pharma-Bio Serv (PBSV) Equity Ratio (2010 - 2026)

Pharma-Bio Serv's Equity Ratio history runs 16 years deep, the most recent figure standing at 0.91 for Q2 2026.

• Equity Ratio for Q2 2026 came in at 0.91, up 4.26% year-over-year; the trailing twelve-month figure through Apr 2026 was 0.91 (up 4.26% YoY), and the FY2025 annual result was 0.87, up 3.66% from the prior year.
• Equity Ratio came in at 0.91 for Q2 2026 at Pharma-Bio Serv, up from 0.76 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.91 in Q2 2026 to a low of 0.74 in Q1 2024.
• A 5-year average of 0.81 and a median of 0.8 in 2022 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio gained 11.99% in 2022 and slipped 6.04% in 2023, its largest moves.
• Over 5 years, Equity Ratio stood at 0.8 in 2022, then rose by 1.06% to 0.81 in 2023, then advanced by 3.89% to 0.84 in 2024, then grew by 3.66% to 0.87 in 2025, then advanced by 4.18% to 0.91 in 2026.
• The last three Equity Ratio figures came in at 0.91 (Q2 2026), 0.76 (Q1 2026), and 0.87 (Q4 2025), per Business Quant data.